In summary, here we report that ART controls the functional polarization of MDSCs through PI3K/AKT, mTOR, and MAPK pathways and inhibition of MDSCs by ART may provide a novel therapeutic strategy to enhance anti-PD-L1 cancer immunotherapy. The gene discussed is AKT1; the disease is cancer.